Sinovac Biotech (SVA) Posts Breakeven Q3 Loss

Sinovac Biotech (NASDAQ: SVA) reported Q3 EPS of $0.00, versus $0.04 reported last year. Revenue for the quarter came in at $17.1 million, versus $22.1 million reported last year.

For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c